Magellan LongevityReviews podcast › Quercetin
M
Magellan Longevity Reviews

Quercetin — research review 3

A short, evidence-grounded conversation about Quercetin and its place in longevity science.

Speaker 1
...and quercetin, a polyphenol found in many fruits and vegetables, really stands out. It's considered a senolytic, meaning it can selectively induce programmed cell death in senescent cells – often called "zombie cells."
Speaker 2
Right, and that's critical because these senescent cells secrete inflammatory molecules, contributing to aging and age-related conditions. Quercetin's ability to clear them is a major interest for longevity research.
Speaker 1
Exactly. A study in Nature Medicine in 2018 demonstrated its senolytic properties in mice, showing it reduced senescent cell burden and improved healthspan in various tissues. It’s also involved in pathways like autophagy and proteostasis, which are vital for cellular housekeeping.
Speaker 2
So, we've got good mechanistic understanding and promising animal data. But what about humans? That's where it gets more complex, isn't it?
Speaker 1
Absolutely. That’s the big open question. While we see these benefits in preclinical models, robust, large-scale human trials demonstrating a direct causal link between quercetin supplementation and extended human healthspan or lifespan are still largely unproven. We don't fully understand optimal dosing, long-term safety profiles across diverse populations, or even if the observed animal benefits translate effectively to humans.
Speaker 2
So, while the evidence is compelling for its potential, we're still waiting on definitive proof of its efficacy as a longevity intervention in people. It’s an exciting area, but the human story is definitely still being written.
Read the Quercetin monograph → Explore the Pathway Universe  🌌 ← All episodes

Educational research discussion only — not medical advice. Statements have not been evaluated by the FDA. Nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to a qualified clinician before changing any treatment.